​

Aligos Therapeutics Ownership | Who Owns Aligos Therapeutics?

OverviewForecastRevenueFinancialsChart

Aligos Therapeutics Ownership Summary

Aligos Therapeutics is owned by 17.80% insiders, and 82.20% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.67% of its assets in Aligos Therapeutics shares.

ALGS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAligos Therapeutics-17.80%82.20%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-80---1---
Jun 30, 202448-5.88%47,289,2312.33%300.59%17-29.17%13160.00%
Mar 31, 20245127.50%46,213,7821.91%710.66%2441.18%5-28.57%
Dec 31, 20234011.11%45,349,61876.22%1042.94%17240.00%7-30.00%
Sep 30, 202336-14.29%25,734,205-2.11%591.59%5-37.50%10-23.08%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv99.66K1.67%-
Vanguard US Total Market Shares ETF52.80K0.86%-
Vanguard Institutional Extnd Mkt Idx Tr39.18K0.66%4.76K
Fidelity Extended Market Index13.64K0.22%-87.00
Schwab US Small-Cap ETF™11.43K0.19%-
Extended Equity Market Fund K5.33K0.09%16.00
Northern Trust Extended Eq Market Idx2.87K0.08%1.43K
Dimensional US Small Cap ETF4.88K0.08%-
Fidelity Total Market Index4.34K0.07%-
Fidelity Series Total Market Index3.31K0.05%57.00

Recent Insider Transactions

DateNameRoleActivityValue
Oct 25, 2023Nuechterlein Carole Buy$6.00M
Oct 25, 2023Nuechterlein Carole Buy$3.00M
Oct 20, 2020Novo Holdings A/S-Buy$3.00M
Oct 20, 2020Woiwode Thomas-Buy$3.00M
Oct 20, 2020Vivo Capital VIII, LLC-Buy$7.25M

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q42-

ALGS Ownership FAQ

Who Owns Aligos Therapeutics?

Aligos Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 17.80% insiders and 82.20% retail investors. The average institutional ownership in Aligos Therapeutics's industry, Biotech Stocks , is 68.48%, which Aligos Therapeutics falls below.

Does Blackrock own Aligos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aligos Therapeutics.

Who is the top mutual fund holder of Aligos Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aligos Therapeutics shares, with 1.67% of its total shares outstanding invested in 99.66K Aligos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools